Skip to main content
An official website of the United States government

Breast and Gynecologic Cancers

Conducts and fosters research on the prevention and early detection of breast cancer, cervix and human papillomavirus (HPV)-related cancers, endometrial cancers, ovarian cancers, and related precursor conditions.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Resources

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Altshuler, Rachel, Ph.D.
rachel.altshuler@nih.gov
240-276-5873
5E304 Program Officer | Breast and Gynecologic Cancer
Asefa, Mela
mela.asefa@nih.gov
240-276-6422
5E328 Program Support Assistant | Breast and Gynecologic Cancer
Program Support Assistant | Prostate and Urologic Cancer
Brofsky, Emma, M.S.P.H.
emma.brofsky@nih.gov
240-276-7532
5E314 Program Analyst | Breast and Gynecologic Cancer
Dimond, Eileen, R.N., M.S.
eileen.dimond@nih.gov
240-276-7086
5E332 Nurse Consultant | Breast and Gynecologic Cancer
Frech, Maria Silvina, Ph.D., M.S.
maria.frech@nih.gov
240-276-5302
5E320 Program Officer | Breast and Gynecologic Cancer
Heckman-Stoddard, Brandy, Ph.D., M.P.H.
brandy.heckman-stoddard@nih.gov
240-276-7048
5E334 Chief | Breast and Gynecologic Cancer
Acting Chief | Community Oncology and Prevention Trials
Perloff, Marjorie, M.D.
marjorie.perloff@nih.gov
240-276-7097
5E544 Program Officer | Breast and Gynecologic Cancer
Rubinstein, Wendy, M.D., Ph.D.
wendy.rubinstein@nih.gov
5E436 Program Officer | Breast and Gynecologic Cancer
Sahasrabuddhe, Vikrant, M.B.B.S., M.P.H., Dr.P.H.
vikrant.sahasrabuddhe@nih.gov
240-276-7332
5E444 Deputy Chief | Breast and Gynecologic Cancer
Samimi, Goli, Ph.D., M.P.H.
goli.samimi@nih.gov
240-276-6582
5E336 Program Officer | Breast and Gynecologic Cancer
Sauter, Edward, M.D., Ph.D.
edward.sauter@nih.gov
240-276-7657
5E338 Program Officer | Breast and Gynecologic Cancer
Streck, Brennan, Ph.D., RN, M.P.H.
brennan.streck@nih.gov
240-276-7050
5E430 Program Officer | Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials
White, Vanessa A., M.P.H.
vanessa.white@nih.gov
240-276-6163
5E524 Program Officer | Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials
Wood (Gunn), Kristen, B.S.N.
kristen.gunn@nih.gov
5E326 Nurse Consultant | Breast and Gynecologic Cancer

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Iyer, Prasad G.

Mayo Clinic Arizona
United States

Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 2R01CA241164-07 Matthew Young, Ph.D.
Jacob, Jennifer B

Henry Ford Health + Michigan State University Health Sciences
United States

Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice 5R01CA278818-03
James, Aimee S

Washington University
United States

Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub 3UG1CA286946-02S1 Elyse LeeVan, M.D., M.P.H.
Jang, Mi-Hyeon

Rutgers Biomedical And Health Sciences
United States

Identification of novel biomarkers and therapeutic strategies in chemobrain. 5R01CA293210-02 John Clifford, Ph.D.
Jaslowski, Anthony J

St. Vincent Hospital
United States

Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium 3UG1CA239769-06S1 Vanessa A. White, M.P.H.
Ji, Hanlee P

Stanford University
United States

Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection 5U01CA282212-02 Claire Zhu, Ph.D.
Ji, Hanlee P

Stanford University
United States

Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification 5P01CA265772-03 Asad Umar, D.V.M., Ph.D.
Jiang, Qing

Purdue University
United States

Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model 5R03CA283236-02 Amit Kumar, Ph.D.
Jiang, Feng

Biotarget Dx Llc
United States

Plasma microRNA biomarkers for lung cancer diagnosis 7UH3CA251139-05 Guillermo Marquez, Ph.D.
Jim, Heather S.L.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer 5R34CA289918-02 Brennan Streck, Ph.D., RN, M.P.H.
Jim, Heather S.L.

H. Lee Moffitt Cancer Ctr & Res Inst
United States

Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue 5R01CA214647-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Jobin, Christian

University Of Florida
United States

Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer 1R01CA296643-01 Young Kim, Ph.D.
John, Esther M.

Stanford University
United States

Stress, inflammation, and health-related quality of life of long-term breast cancer survivors 1R21CA290430-01 Brennan Streck, Ph.D., RN, M.P.H.
Johnson, Jeremy James

University Of Illinois At Chicago
United States

Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer 5R37CA227101-07 Amit Kumar, Ph.D.
Johnson, Constance Margaret

University Of Texas Hlth Sci Ctr Houston
United States

Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy 3R01CA245054-05S1 Rachel Altshuler, Ph.D.